A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma

<div>The results of principal component analysis. A comparison of gene expression levels in high- and low-risk patients, based on (a) the expression of all examined genes, (b) cuproptosis-associated genes, (c) cuproptosis-associated lncRNAs, and (d) the 5 lncRNAs of the prognostic signature.</div>

Journal of Oncology

fig5

Figure 5

Figure 5: A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma 

Figure 5 | A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma 